Discovery of NR2B-selective antagonists via scaffold hopping and pharmacokinetic profile optimization.
Anan K, Masui M, Tazawa A, Tomida M, Haga Y, Kume M, Yamamoto S, Shinohara S, Tsuji H, Shimada S, Yagi S, Hasebe N, Kai H.
Anan K, et al. Among authors: kume m.
Bioorg Med Chem Lett. 2019 May 1;29(9):1143-1147. doi: 10.1016/j.bmcl.2019.02.017. Epub 2019 Feb 15.
Bioorg Med Chem Lett. 2019.
PMID: 30833109